• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在淋巴结阴性乳腺癌患者手术切除标本中,对Ki67免疫组化进行视觉评估时的观察者间一致性。

Interobserver concordance in visual assessment of Ki67 immunohistochemistry in surgical excision specimens from patients with lymph node-negative breast cancer.

作者信息

Thomas Susanna, Kabir Masrura, Butcher Belinda E, Chou Shaun, Mahajan Hema, Farshid Gelareh, Balleine Rosemary, Pathmanathan Nirmala

机构信息

Westmead Breast Cancer Institute, Westmead, NSW, 2145, Australia.

Western Sydney Local Health District, Westmead, NSW, 2145, Australia.

出版信息

Breast Cancer Res Treat. 2021 Aug;188(3):729-737. doi: 10.1007/s10549-021-06188-6. Epub 2021 Mar 22.

DOI:10.1007/s10549-021-06188-6
PMID:33751322
Abstract

PURPOSE

This study aimed to determine the interobserver concordance of two methods for proliferation assessment in breast cancer using Ki67 immunohistochemistry.

METHODS

Ki67 was independently assessed in randomly selected tumour samples from patients with lymph node-negative breast cancer using two different methods: either cell counting or visual estimation of hot spot areas. For hot spot cell counting, positive and negative cell numbers were recorded for total cell counts of 300-500, 500-800 and 800-1000 cells. Visual estimation involved allocation of a score from 1 to 5 using a visual scale to estimate percentage positivity. Interobserver agreement for hot spot counting was calculated using a two-way fixed effects intraclass correlation model, and by using Cohen's kappa measure for visual assessment. Prognostic concordance between the two methods was also calculated using Cohen's kappa.

RESULTS

Samples from 96 patients were included in this analysis. Interobserver agreement for hot spot cell counting was excellent (> 0.75) across all three cell count ranges, with correlation coefficients of 0.88 (95% CI 0.84-0.92), 0.87 (95% CI 0.82-0.91) and 0.89 (95% CI 0.85-0.92), respectively. Interobserver agreement with visual estimation was greatest for hot spots compared with areas of intermediate or low proliferation, with kappa scores of 0.49, 0.42 and 0.40, respectively. Both assessment methods demonstrated excellent prognostic agreement.

CONCLUSIONS

Interobserver and prognostic concordance in Ki67 immunohistochemistry assessments was high using either hot spot cell counting or visual estimation, further supporting the utility and reproducibility of these cost-efficient methods to assess proliferation.

摘要

目的

本研究旨在确定使用Ki67免疫组织化学评估乳腺癌增殖的两种方法在观察者间的一致性。

方法

使用两种不同方法对随机选取的淋巴结阴性乳腺癌患者的肿瘤样本独立评估Ki67:细胞计数或热点区域视觉估计。对于热点细胞计数,记录300 - 500、500 - 800和800 - 1000个细胞总数中的阳性和阴性细胞数。视觉估计是使用视觉量表从1到5分配一个分数来估计阳性百分比。使用双向固定效应组内相关模型计算热点计数的观察者间一致性,并使用Cohen's kappa测量进行视觉评估。还使用Cohen's kappa计算两种方法之间的预后一致性。

结果

本分析纳入了96例患者的样本。在所有三个细胞计数范围内,热点细胞计数的观察者间一致性都非常好(> 0.75),相关系数分别为0.88(95% CI 0.84 - 至0.92)、0.87(95% CI 0.82 - 0.91)和0.89(95% CI 0.85 - 0.92)。与增殖程度中等或较低的区域相比,热点的视觉估计观察者间一致性最高,kappa分数分别为0.49、0.42和0.40。两种评估方法均显示出良好的预后一致性。

结论

使用热点细胞计数或视觉估计,Ki67免疫组织化学评估中的观察者间一致性和预后一致性都很高,进一步支持了这些经济高效的增殖评估方法的实用性和可重复性。

相似文献

1
Interobserver concordance in visual assessment of Ki67 immunohistochemistry in surgical excision specimens from patients with lymph node-negative breast cancer.在淋巴结阴性乳腺癌患者手术切除标本中,对Ki67免疫组化进行视觉评估时的观察者间一致性。
Breast Cancer Res Treat. 2021 Aug;188(3):729-737. doi: 10.1007/s10549-021-06188-6. Epub 2021 Mar 22.
2
An interobserver reproducibility analysis of size-set semiautomatic counting for Ki67 assessment in breast cancer.乳腺癌中 Ki67 评估的大小设定半自动计数的观察者间可重复性分析。
Breast. 2020 Feb;49:225-232. doi: 10.1016/j.breast.2019.12.009. Epub 2019 Dec 20.
3
An interobserver reproducibility analysis of Ki67 visual assessment in breast cancer.乳腺癌中Ki67视觉评估的观察者间可重复性分析
PLoS One. 2015 May 1;10(5):e0125131. doi: 10.1371/journal.pone.0125131. eCollection 2015.
4
Analytical validation of a standardised scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicentre collaboration.Ki67 免疫组化在乳腺癌全切除标本中的标准化评分方案的分析验证:一项国际多中心合作。
Histopathology. 2019 Aug;75(2):225-235. doi: 10.1111/his.13880. Epub 2019 Jul 8.
5
Visual assessment of Ki67 using a 5-grade scale (Eye-5) is easy and practical to classify breast cancer subtypes with high reproducibility.使用5级量表(Eye-5)对Ki67进行视觉评估,对于乳腺癌亚型分类而言既简单又实用,且具有高度的可重复性。
J Clin Pathol. 2015 May;68(5):356-61. doi: 10.1136/jclinpath-2014-202695. Epub 2015 Feb 11.
6
Interobserver concordance of Ki67 labeling index in breast cancer: Japan Breast Cancer Research Group Ki67 ring study.乳腺癌中 Ki67 标记指数的观察者间一致性:日本乳腺癌研究组 Ki67 环研究。
Cancer Sci. 2013 Nov;104(11):1539-43. doi: 10.1111/cas.12245. Epub 2013 Sep 6.
7
A Comparison of Visual Assessment and Automated Digital Image Analysis of Ki67 Labeling Index in Breast Cancer.乳腺癌中Ki67标记指数的视觉评估与自动数字图像分析比较
PLoS One. 2016 Feb 29;11(2):e0150505. doi: 10.1371/journal.pone.0150505. eCollection 2016.
8
Assessment of tumour proliferation by use of the mitotic activity index, and Ki67 and phosphohistone H3 expression, in early-stage luminal breast cancer.早期 luminal 型乳腺癌中利用有丝分裂活性指数、Ki67 和磷酸化组蛋白 H3 表达评估肿瘤增殖。
Histopathology. 2020 Oct;77(4):579-587. doi: 10.1111/his.14185. Epub 2020 Aug 30.
9
Interobserver Variability of Ki-67 Measurement in Breast Cancer.乳腺癌中Ki-67测量的观察者间差异
J Pathol Transl Med. 2016 Mar;50(2):129-37. doi: 10.4132/jptm.2015.12.24. Epub 2016 Feb 15.
10
Digital image analysis of Ki67 proliferation index in breast cancer using virtual dual staining on whole tissue sections: clinical validation and inter-platform agreement.基于全组织切片虚拟双重染色的乳腺癌 Ki67 增殖指数的数字图像分析:临床验证和平台间一致性。
Breast Cancer Res Treat. 2018 May;169(1):33-42. doi: 10.1007/s10549-018-4669-2. Epub 2018 Jan 18.

引用本文的文献

1
Concordance between core needle biopsy and surgical excision for breast cancer tumor grade and biomarkers.核心针穿刺活检与手术切除在乳腺癌肿瘤分级和生物标志物方面的一致性。
Breast Cancer Res Treat. 2022 May;193(1):151-159. doi: 10.1007/s10549-022-06548-w. Epub 2022 Feb 28.